Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Bicycle Therapeutics

Request full access

Therapeutics based on its proprietary bicyclic peptide product platform

Cambridge, United KingdomFounded 2009Biotech & Life Sciences

At a glance

Status
Listed
Listing
IPO 2019

Bicycle Therapeutics in the Cambridge ecosystem

Live from Dealroom

The Bicycle Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

16 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Novartis Venture Fund

Series A4 investors entered at this stage

Series B and later11 investors entered at this stage

  • Fairmount Funds Management
  • Forbion Capital Partners
  • Cambridge Innovation Capital
  • Longwood Fund
  • University of Cambridge
  • Vertex Ventures HC
  • EPFL Swiss Federal Polytechnic School of Lausanne
  • Deep Track Capital
  • EcoR1 Capital
  • Perceptive Advisors
  • RA Capital Management
Employees mapped 271 incl. 8 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 6 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$117M

75 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See Bicycle Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.